Adenosine is a purine nucleoside that is present in all human cells and is essential for regulating certain physiological activities in tissues and organs. Since adenosine is considered to be a potential cancer biomarker in urine, its determination may be crucial for the early diagnosis and non-invasive monitoring of cancer. Herein, we present a label-free method to quantify urinary adenosine using surface-enhanced Raman spectroscopy (SERS) and multivariate curve resolution-alternating least squares (MCR-ALS). Ring-oven preconcentration and direct deposition of monodisperse gold nanoparticles on filter paper were employed to improve the sampling efficiency. Further, MCR-ALS (assessed with and without a correlation constraint), the standard addition method and pH controls were combined to compensate for the matrix effect and to address overlapping bands in the analysis of human urine samples. As a result, the proposed method showed to be sensitive (LOD varying between 3.8 and 4.9 µmol L, S/R = 3), reproducible (RSD less than ± 15%), and selective over other nucleosides (guanosine, cytidine, thymidine and uridine) and unknown interferences (second-order advantage). This is the first report of a SERS-chemometric method applied to urinary adenosine sensing at physiologically relevant concentrations, with minimal sample preparation, and has strong potential to be a valuable tool in cancer research.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.talanta.2018.05.022 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!